7,579 followers
Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial. https://t.co/AFJwQnz2jR #microbiome https://t.co/VbZV7p5FXU
Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial. https://t.co/AFJwQnz2jR #microbiome https://t.co/VbZV7p5FXU
Just published: Protocol for a randomised controlled trial to modulate the gut #microbiota with Rifaximine to attenuate liver fibrosis https://t.co/O3b7dKdrCv #H2020 @Norgine #alcoholicliverdisease